Skip to main content

Table 3 Characteristics of studies included in the meta-analysis

From: Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis

Author

Design

Study population

Study period and outcome

Case/Control

Coffee consumption

Risk estimate (95% CI)

Covariate adjustments

Kuper et al. [11], 2000

HCCS

Greece

1995–1998 HCC incidence

333/360

Nondrinkers

1

Age, gender, years of schooling, HBsAg and/or anti-HCV status

<20 cups/week

1.1 (0.5–2.6)

≥20 cups/week

0.9 (0.4–2.5)

Gallus et al. [12], 2002

HCCS

Greece Italy

1995–1998

834/1912

Nondrinkers

1.0

Age, sex, smoking, alcohol drinking, history of diabetes or hepatitis, education, BMI

1984–1997 HCC incidence

1 cup/day

1.2 (0.9–1.6)

2 cup/day

1.0 (0.7–1.3)

≥3 cups/day

0.7 (0.5–1.0)

Shimazu et al. [20], 2005

CS1

Japan

1984–1992 Primary liver cancer incidence

70/22404

Nondrinkers

1.0

Age, sex, smoking, alcohol drinking, history of liver disease

occasionally

0.56 (0.33–0.97)

≥1 cups/day

0.53 (0.28–1.00)

Shimazu et al. [20], 2005

CS2

Japan

1990–1997 Primary liver cancer incidence

47/38703

Nondrinkers

1.0

Age, sex, smoking, alcohol drinking, history of liver disease

occasionally

1.05 (0.52~2.16)

≥1 cups/day

0.68 (0.31~1.51)

Kurozawa et al. [22], 2005

CS

Japan

1988–1999 HCC mortality

258/83966

Total

 

Age, sex, smoking, alcohol habits, history of diabetes or liver disease, education

Nondrinkers

1.0

<1 cup/day

0.83 (0.54–1.25)

≥1 cup/day

0.50 (0.31–0.79)

Men

 

Nondrinkers

1.0

<1 cup/day

0.91(0.57–1.45)

≥1 cup/day

0.49(0.28–0.85)

Women

 

Nondrinkers

1.0

<1 cup/day

0.64 (0.27–1.51)

≥1 cup/day

0.51 (0.20–1.31)

Inoue et al. [21], 2005

CS

Japan

1990–2001 HCC incidence

334/90452

Men and women

 

Age, sex, study area, ethanol intake, green vegetable, green tea and smoking

Almost never

1.0

1–2 day/week

0.75 (0.56–1.01)

3–4 day/week

0.79 (0.55–1.14)

1–2 cups/day

0.52 (0.38–0.73)

3–4 cups/day

0.48 (0.28–0.83)

≥5 cups/day

0.24 (0.08–0.77)

Men

 

Almost never

1.0

1–2 day/week

0.74 (0.52–1.05)

3–4 day/week

0.76 (0.50–1.16)

1–2 cups/day

0.55 (0.38–0.80)

3–4 cups/day

0.41 (0.21–0.77)

≥5 cups/day

0.27 (0.09–0.87)

women

 

Almost never

1.0

1–2 day/week

0.77 (0.43–1.37)

3–4 day/week

0.89 (0.43–1.84)

1–2 cups/day

0.43 (0.20–0.90)

3–4 cups/day

0.89 (0.31–2.59)

≥5 cups/day

-----

Gelatti et al. [13], 2005

HCCS

Italy

1994–2003 HCC incidence

250/500

Nondrinkers

1.0

Age, sex, alcohol drinking, HBV and/or HCV infection

1–2 cups/day

0.8 (0.4–1.3)

3–4 cups/day

0.4 (0.2–0.8)

≥5 cups/day

0.3 (0.1–0.7)

Ohfuji et al. [14], 2006

HCCS

Japan

2001–2002 HCC incidence

73/253

Nondrinkers

1.0

Age, sex, smoking, alcohol drinking, time since first identification of liver disease, BMI, disease severity, family history of liver disease, interferon therapy

<1 cup/day

0.61 (0.18–2.03)

≥1 cup/day

0.38 (0.13–1.12)

Tanaka et al. [15], 2007

PCCS

Japan

2001–2004 HCC incidence

209/1253

Nondrinkers

1.0

Age, sex, smoking status, heavy alcohol drinking,

occasionally

0.33 (0.22~0.48)

1–2 cups/day

0.27 (0.15~0.48)

≥3 cups/day

0.22 (0.11~0.43)

Montella et al. [16], 2007

HCCS

Italy

1999–2002 HCC incidence

185/412

Abstainers

2.28 (0.99–5.24)

Age, sex, alcohol drinking, HBV and/or HCV infection, education, smoking, alcohol drinking

<14 cups/week

1.0

14–20 cups/week

0.54 (0.27–1.07)

21–27 cups/week

0.57 (0.25–1.32)

≥28 cups/week

0.43 (0.16–1.13)

Wakai et al. [17], 2007

NCCS

Japan

1988–1990 HCC incidence

96/3444

Nondrinkers

1.0

Age, sex, smoking, alcohol drinking, consumption of areca,educational levels, ethnicity,source of hospital

<1 cup/day

0.77 (0.45–1.32)

≥1 cup/day

0.49 (0.25–0.96)

Hu et al. [23], 2008

CS

Finland

1997–2002 HCC incidence

128/60323

Total

 

Age, sex, smoking, alcohol drinking, education, study year, diabetes and chronic liver disease BMI and during follow up.

0–1 cup/day

1.0

2–3 cups/day

0.66 (0.37–1.16)

4–5 cups/day

0.44 (0.25–0.77)

6–7 cups/day

0.38 (0.21–0.69)

≥8 cups/day

0.32 (0.16~0.62)

Men

 

0–1 cup/day

1.0

2–3 cups/day

0.68 (0.35–1.31)

4–5 cups/day

0.35 (0.18–0.71)

6–7 cups/day

0.31 (0.15–0.63)

≥8 cups/day

0.28 (0.13–0.61)

Women

 

0–1 cup/day

1.0

2–3 cups/day

0.62 (0.19–2.04)

4–5 cups/day

0.60 (0.20–1.82)

6–7 cups/day

0.58 (0.19–1.82)

≥8 cups/day

0.41 (0.10–1.70)

Ohishi et al. [18], 2008

NCCS

Japan

1999–2002 HCC incidence

224/644

Nondrinkers

1.0

Hepatitis virus infection, alcohol consumption, smoking habits, BMI, diabetes mellitus, and radiation dose to the liver

Daily

0.40 (0.16–1.02)

Inoue et al. [24], 2009

CS

Japan

1993–1994 HCC incidence

110/18815

Total

 

Age, sex, area, smoking, alcohol drinking, BMI, diabetes mellitus, green tea consumption, serum ALTlevel, and HBV and HCV infection status

Almost never

1.0

<1 cup/day

0.67 (0.42–1.07)

1–2 cups/day

0.49 (0.27–0.91)

≥3 cups/day

0.54 (0.21–1.39)

Men

 

Almost never

1.0

<1 cup/day

0.79 (0.46–1.37)

1–2 cups/day

0.37 (0.17–0.81)

≥3 cups/day

0.32 (0.10–1.10)

Women

 

Almost never

1.0

<1 cup/day

0.39 (0.15–1.03)

1–2 cups/day

0.92 (0.36–2.38)

≥3 cups/day

0.69 (0.11–4.22)

Johnson et al. [25], 2011

CS

Chinese

1993–2006 HCC incidence

362/61321

Nondrinkers

1.0

Age at recruitment, sex, dialect group, year of recruitment, BMI, level of education, consumption of alcoholic beverages, smoking, black tea and green tea intake, and history of diabetes.

0-<1 drinkers/day

0.94 (0.63–1.40)

1-<2 drinkers/day

1.17 (0.87–1.56)

2-<3 drinkers/day

0.78 (0.56–1.07)

≥3 drinkers/day

0.56 (0.31–1.00)

Leung et al. [19], 2011

HCCS

HongKong

2007–2008 HCC incidence

109/125

<1 time/week

1.0

Age, sex, alcohol drinking, cigarette smoking, tea consumption and physical activity

     

1–3 times/week

0.58 (0.24–1.36)

 
     

≥4 times/week

0.41 (0.19–0.89)

 
  1. ALT: alanine aminotransferase; BMI: body mass index; CI: confidence interval; HbsAg: hepatitis B surface antigen; HCCS: hospital-based case–control study; PCCS: population-based case–control study; NCCS: nested case–control study; CS: cohort study; HCC: hepatocellular carcinoma.